Cancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerHead & Neck/Thyroid CancersMelanomaGastrointestinal CancerGenitourinary Cancer
Neoadjuvant immunotherapy shows promise for resectable CSCCSeptember 27, 2022Head & Neck/Thyroid Cancers
FDA OKs selpercatinib for adults with RET-fusion+ solid tumorsSeptember 23, 2022Lung CancerHead & Neck/Thyroid CancersGastrointestinal CancerMetastatic Breast Cancer
High BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Pembro/chemo combo fails to improve event-free survival in head and neck cancerSeptember 14, 2022Head & Neck/Thyroid Cancers
First drug for desmoid tumors: ‘Impressive’ data for nirogacestatSeptember 13, 2022Gastrointestinal CancerHead & Neck/Thyroid Cancers
Nearly 30% of U.S. cancer deaths linked to smokingAugust 30, 2022Lung CancerPreventive CareHead & Neck/Thyroid Cancers
Oncologists often misinterpret posttreatment HNSCC scan detailsAugust 29, 2022Head & Neck/Thyroid Cancers
Thyroid autoimmunity linked to cancer, but screening not advisedAugust 29, 2022Head & Neck/Thyroid Cancers
The ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
